Oritavancin as sequential therapy for Gram-positive bloodstream infections
Abstract Background Oritavancin, a long-acting lipoglycopeptide approved for use in acute bacterial skin and skin structure infections, has limited data evaluating use in serious infections due to Gram-positive organisms.We aimed to assess the effectiveness and safety of oritavancin for consolidative treatment of Electric Knife Gram-positive bloods